Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Cotran 2, Boston, MA 02115, USA.
Clin Lab Med. 2020 Mar;40(1):1-12. doi: 10.1016/j.cll.2019.11.007.
With the ever-increasing market share of direct-to-consumer (DTC) testing, projected to surpass $350 million this year, health care professionals must address the health literacy gap that exists between what the clinician knows and what the general public understands about clinical laboratory testing. Health literacy is lowest among people with lower socioeconomic status and results in poorer outcomes. However, these individuals represent those that would benefit most from valuable DTC testing. There is a need for unbiased and universally accessible tools to help improve consumers' understanding of test utility, limitations to the accuracy of results, and result interpretation.
随着直接面向消费者(DTC)检测市场份额的不断增长,预计今年将超过 3.5 亿美元,医疗保健专业人员必须解决临床医生所知道的和普通公众对临床实验室检测的理解之间存在的健康素养差距。社会经济地位较低的人群健康素养最低,导致结果更差。然而,这些人正是最能从有价值的 DTC 检测中受益的人群。需要使用公正且普遍适用的工具来帮助提高消费者对检测效用、结果准确性的局限性以及结果解释的理解。